Michael Auffret




Michael Aufret is a leading contributor to Imaging Phenomics, cuurently Senior Director and iBiopsy® Program Managemer at Median Technologies in Sophia Antipolis. Imaging phenomena should play an increasingly important role in the development and clinical evaluation of targeted therapies. New AI-based algorithms are needed to process large amounts of phenotypic data and extract actionable information. Cloud computing will pave the way for large-scale image phenotyping and facilitate the translation of new knowledge about new therapies and therapeutic strategies.